Search Results
Exploratory analyses from JAVELIN Bladder 100
Drs. Powles, Koshkin on the Q-TWiST Analysis for JAVELIN Bladder 100
JAVELIN Bladder 100: duration of treatment-free interval
Results from the JAVELIN Ovarian 200 biomarker analysis
JAVELIN Bladder 100 trial: Biomarkers for maintenance avelumab in metastatic urothelial cancer
The JAVELIN Bladder 100 Phase III Trial Results
Exploratory data suggest potential of epigenetic biomarkers in advanced UC | Joaquim Bellmunt
Researcher comment: The JAVELIN Bladder 100 trial | Thomas Powles
JAVELIN Bladder 100: Avelumab maintenance for metastatic or locally advanced bladder cancer
Systemic Treatment of Bladder Cancer: The Benefits of Clinical Pathways
Avelumab 1L Maintenance Treatment in Advanced Bladder Cancer: Practical Steps for Infusion Nurses
"Updates in Treatment of Metastatic Bladder Cancer" by Jason Brown, MD, PhD
